Outcomes of Children with Well-Differentiated Fetal Hepatoblastoma Treated with Surgery Only: Report from Children's Oncology Group Trial, AHEP0731

• Published in: Journal of pediatric surgery Vol. 57; no. 10; pp. 251 - 256
• Main Authors: Vasudevan, Sanjeev A, Meyers, Rebecka L, Finegold, Milton J, López-Terrada, Dolores, Ranganathan, Sarangarajan, Dunn, Stephen P, Langham, Max R, McGahren, Eugene D, Tiao, Greg M, Weldon, Christopher B, Malogolowkin, Marcio H, Krailo, Mark D, Piao, Jin, Randazzo, Jessica, Towbin, Alexander J, McCarville, M. Beth, O'Neill, Allison F, Furman, Wayne L, Rodriguez-Galindo, Carlos, Katzenstein, Howard M
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.10.2022
• Subjects: Fetal; Hepatoblastoma; Level I evidence; Level of Evidence; Prognosis Study; Resection; Well-differentiated; Well-differentiated; Resection; PRETEXT; C; OS; Level of Evidence; E; F; Fetal; AFP; Level I evidence; N; and M; Prognosis Study; CR; P; R; PFH; EFS; V; WDF; HB; COG; Hepatoblastoma
• ISSN: 0022-3468; 1531-5037
• DOI: 10.1016/j.jpedsurg.2022.05.022

•Pure or well differentiated fetal histology has the best outcomes out of all hepatoblastoma histologies.•Well differentiated fetal tumor surgically removed at diagnosis are curable without adjuvant chemotherapy. Background: Hepatoblastoma (HB) requires surgical resection for cure, but only 20-30% of patients have resectable disease at diagnosis. Patients who undergo partial hepatectomy at diagnosis have historically received 4-6 cycles of adjuvant chemotherapy; however, those with 100% well-differentiated fetal histology (WDF) have been observed to have excellent outcomes when treated with surgery alone. Patients and methods: Patients on the Children's Oncology Group non-randomized, multicenter phase III study, AHEP0731, were stratified based on Evan's stage, tumor histology, and serum alpha-fetoprotein level at diagnosis. Patients were eligible for the very low-risk stratum of surgery and observation if they had a complete resection at diagnosis and rapid central histologic review demonstrated HB with 100% WDF histology. Results: A total of 8 eligible patients were enrolled on study between September 14, 2009 and May 28, 2014. Outcome current to 06/30/2020 was used in this analysis. The median age at enrollment was 22.5 months (range: 8-84 months) and the median AFP at enrollment was 714 ng/ml (range: 18-77,747 ng/mL). With a median follow-up of 6.6 years (range: 3.6-9.8 years), the 5-year event-free (EFS) and overall survival (OS) were both 100%. Conclusion: This report supports that HB with 100% WDF histology completely resected at diagnosis is curable with surgery only. The development of evidence-based surgical guidelines utilizing criteria based on PRETEXT group, vascular involvement (annotation factors), tumor-specific histology and corresponding biology will be crucial for optimizing which patients are candidates for resection at diagnosis followed by observation.